Tag: intranasal
Intravacc launches phase I clinical trial of Avacc 10, an intranasal...
Randomized, double blinded, placebo-controlled trial. Evaluation of two doses in 36 volunteers. Mid-term data expected by end Q1 2023
Bharat Biotech’s iNCOVACC, world’s first Intra Nasal vaccine, gets emergency use...
Heterologous booster dose studies were conducted for safety and immunogenicity in ~875 subjects at 9 trial sites across India
China focuses on next-generation intranasal COVID-19 vaccines amid rising mutant strains
Several pharmaceutical companies across the world have started working on the inhaled vaccine formulations and China is also developing next-generation intranasal COVID-19 vaccines, says GlobalData....................























































